What is the effect of adding teriparatide or abaloparatide to alendronate therapy in patients with osteoporosis?
Evidence from high-quality studies demonstrates that sequential therapy with abaloparatide or teriparatide followed by alendronate increases bone density and reduces fracture risk in patients with osteoporosis, compared to placebo followed by alendronate.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24172956
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00